Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens
Breast cancer resistance protein (BCRP), an ATP-binding cassette transporter, confers resistance to a series of anticancer reagents such as mitoxantrone, 7-ethyl-10-hydroxycamptothecin, and topotecan. We reported previously that estrone and 17β-estradiol reverse BCRP-mediated multidrug resistance....
Saved in:
Published in | Molecular pharmacology Vol. 64; no. 3; pp. 610 - 618 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Pharmacology and Experimental Therapeutics
01.09.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Breast cancer resistance protein (BCRP), an ATP-binding cassette transporter, confers resistance to a series of anticancer
reagents such as mitoxantrone, 7-ethyl-10-hydroxycamptothecin, and topotecan. We reported previously that estrone and 17β-estradiol
reverse BCRP-mediated multidrug resistance. In the present study, we demonstrate that BCRP exports estrogen metabolites.
First, we generated BCRP -transduced LLC-PK1 (LLC/BCRP) cells, in which exogenous BCRP is expressed in the apical membrane, and investigated transcellular
transport of 3 H-labeled compounds using cells plated on microporous filter membranes. The basal-to-apical transport (excretion) of mitoxantrone,
estrone, and 17β-estradiol was greater in LLC/BCRP cells than in LLC-PK1 cells. Thin-layer chromatography of transported
steroids revealed that the transport of estrone and 17β-estradiol was independent of BCRP expression. Alternatively, increased
excretion of estrone sulfate and 17β-estradiol sulfate was observed in LLC/BCRP cells. BCRP inhibitors completely inhibited
the increased excretion of sulfated estrogens across the apical membrane. Conversion of estrogens into their sulfate conjugates
was similar between LLC/BCRP and LLC-PK1 cells, suggesting that the increased excretion of estrogen sulfates was attributable
to BCRP-mediated transport. Next, the uptake of 3 H-labeled compounds in membrane vesicles from BCRP -transduced K562 (K562/BCRP) cells was investigated. 3 H-labeled estrone sulfate, but not 3 H-labeled estrone or 17β-estradiol, was taken up by membrane vesicles from K562/BCRP cells, and this was ATP-dependent. Additionally,
BCRP inhibitors suppressed the transport of estrone sulfate in membrane vesicles from K562/BCRP cells. These results suggest
that BCRP does not transport either free estrone or 17β-estradiol but exports sulfate conjugates of these estrogens. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0026-895X 1521-0111 |
DOI: | 10.1124/mol.64.3.610 |